Pure Extracts (CSE: PULL) has entered into a letter of intent for a proposed joint venture with Psyence Group (CSE: PSYG). The proposed venture is to be focused on the extraction of psilocybin from mushrooms. The venture partner, Psyence, is one of the first commercial psilocybin cultivation and extraction facilities operating under a federally legal …
Psyched Wellness Launches Study On Mushroom Extract Focused On Gut Health
Psyched Wellness (CSE: PSYC) this morning issued a very brief press release related to ongoing studies. The firm has initiated yet another study on its proprietary AME-1 extract, this time with the study focused on gut health. To be conducted through the firms contract research organization, KGK Sciences, the study will look to further examine …
Mind Medicine Boasts Current Cash Position Of US$161 Million
Mind Medicine (NEO: MMED) this morning released its fiscal year 2020 financial results. Given that the firm is pre-revenue, the filings are a relative non-event aside from the glimpse it provides into the firms research activities as well as its ability to continue to fund such research. The fiscal year saw the company use a …
PharmaTher Sponsors Research For Novel Delivery Of Ketamine
PharmaTher Inc (CSE: PHRM) this morning announced that it has entered into a sponsored research agreement. The agreement, which was signed with The Queen’s University of Belfast, will see the development of a patented hydrogel-forming microneedle patch for use with ketamine. More specifically, the microneedle patch is being developed to work with KETABET, PharmaTher’s proprietary …
JR Rahn: Using LSD To Treat Mental Health – The Daily Dive
For our Saturday edition of The Daily Dive, host Cassandra Leah sits down with that of JR Rhan, founder and co-CEO of Mind Medicine (NEO: MMED). JR joins us to discuss operating in the mental health space, why the firm elected to study MDMA and LSD, and the stigma associated with such compounds that the …
Revive Therapeutics Reports Successful Results Using Psilocybin To Treat Traumatic Brain Injury
Revive Therapeutics (CSE: RVV) this morning revealed that it has received positive results for a pre-clinical study that evaluated the efficacy of psilocybin in the treatment of mild traumatic brain injury. The pre-clinical trial was conducted in a rodent model of such an injury. Conducted by the National Health Research Institute, the study focused on …
Psyched Wellness Files Patent Application For Proprietary AME-1 Extraction Process
Psyched Wellness (CSE: PSYC) has begun the process of protecting its intellectual property. The firm this morning announced that it has submitted a provisional patent application with that of the United States Patent and Trademark Office. The provisional patent application is for that of the firms extraction process for the Amanita Muscaria extract AME-1. The …
Red Light Holland Sees Sales And Import Of Psychedelic Truffles Into Canada
Red Light Holland (CSE: TRIP) this morning reported that it has seen the successful sale and import of its psychedelic truffles, referred to as iMicrodose Packs, into Canada under a Health Canada permit. The transaction saw the firms products imported by CCrest Laboratories, in partnership with Shaman Pharma. The arrangement is significant for Red Light, …
Numinus Wellness To Conduct $30 Million Bought Deal
Numinus Wellness (TSXV: NUMI) this morning announced that it will be raising funds again. The latest round being conducted by the company will look to raise $30.0 million in a bought deal offering lead by Eight Capital and Canaccord Genuity. The financing will see units of the company sold at a price of $1.25 per …
Creso Pharma Enters Psychedelics Space With Acquisition Of Canadian Firm
Creso Pharma (ASX: CPH) this morning announced that it will be entering the psychedelic space, the first such listed firm on the ASX to do so. The company is set to acquire Halucenex, a psychedelic-assisted psychotherapy firm based in Canada. The acquisition will bring the company into the emerging psychedelics sector, which is estimated to …